431 related articles for article (PubMed ID: 22244046)
1. Intravenous Lacosamide in refractory nonconvulsive status epilepticus.
Mnatsakanyan L; Chung JM; Tsimerinov EI; Eliashiv DS
Seizure; 2012 Apr; 21(3):198-201. PubMed ID: 22244046
[TBL] [Abstract][Full Text] [Related]
2. Factors influencing response to intravenous lacosamide in emergency situations: LACO-IV study.
Garcés M; Villanueva V; Mauri JA; Suller A; García C; López González FJ; Rodríguez Osorio X; Fernández Pajarín G; Piera A; Guillamón E; Santafé C; Castillo A; Giner P; Torres N; Escalza I; Del Villar A; García de Casasola MC; Bonet M; Noé E; Olmedilla N
Epilepsy Behav; 2014 Jul; 36():144-52. PubMed ID: 24922617
[TBL] [Abstract][Full Text] [Related]
3. Intravenous lacosamide in status epilepticus and seizure clusters.
Höfler J; Unterberger I; Dobesberger J; Kuchukhidze G; Walser G; Trinka E
Epilepsia; 2011 Oct; 52(10):e148-52. PubMed ID: 21801171
[TBL] [Abstract][Full Text] [Related]
4. Intravenous lacosamide as treatment option in post-stroke non convulsive status epilepticus in the elderly: a proof-of-concept, observational study.
Belcastro V; Vidale S; Pierguidi L; Sironi L; Tancredi L; Striano P; Taborelli A; Arnaboldi M
Seizure; 2013 Dec; 22(10):905-7. PubMed ID: 23953988
[TBL] [Abstract][Full Text] [Related]
5. The Safety and Effectiveness of Intravenous Lacosamide for Refractory Status Epilepticus in the Critically Ill.
Newey CR; Le NM; Ahrens C; Sahota P; Hantus S
Neurocrit Care; 2017 Apr; 26(2):273-279. PubMed ID: 27844464
[TBL] [Abstract][Full Text] [Related]
6. Intravenous lacosamide in seizure emergencies: Observations from a hospitalized in-patient adult population.
d'Orsi G; Pascarella MG; Martino T; Carapelle E; Pacillo F; Di Claudio MT; Mancini D; Trivisano M; Avolio C; Specchio LM
Seizure; 2016 Nov; 42():20-28. PubMed ID: 27693808
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of intravenous lacosamide in refractory nonconvulsive status epilepticus.
Koubeissi MZ; Mayor CL; Estephan B; Rashid S; Azar NJ
Acta Neurol Scand; 2011 Feb; 123(2):142-6. PubMed ID: 21198444
[TBL] [Abstract][Full Text] [Related]
8. Intravenous lacosamide in clinical practice-Results from an independent registry.
Lang N; Lange M; Schmitt FC; Bös M; Weber Y; Evers S; Burghaus L; Kellinghaus C; Schubert-Bast S; Bösel J; Lammers T; Sabolek M; van Baalen A; Dziewas R; Kraft A; Ruf S; Stephani U
Seizure; 2016 Jul; 39():5-9. PubMed ID: 27161669
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Recurrent Electrographic Nonconvulsive Seizures (TRENdS) study.
Husain AM
Epilepsia; 2013 Sep; 54 Suppl 6():84-8. PubMed ID: 24001083
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of intravenous lacosamide as an add-on treatment in refractory status epilepticus: a multicentric prospective study.
Miró J; Toledo M; Santamarina E; Ricciardi AC; Villanueva V; Pato A; Ruiz J; Juvany R; Falip M
Seizure; 2013 Jan; 22(1):77-9. PubMed ID: 23127776
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of intravenous lacosamide in refractory nonconvulsive status epilepticus and simple partial status epilepticus.
Rantsch K; Walter U; Wittstock M; Benecke R; Rösche J
Seizure; 2011 Sep; 20(7):529-32. PubMed ID: 21489827
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of intravenous lacosamide in status epilepticus.
Santamarina E; Toledo M; Sueiras M; Raspall M; Ailouti N; Lainez E; Porta I; De Gracia R; Quintana M; Alvarez-Sabín J; Xavier Salas Puig XS
J Neurol; 2013 Dec; 260(12):3122-8. PubMed ID: 24122063
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of intravenous lacosamide for adjunctive treatment of refractory status epilepticus: a comparative cohort study.
Sutter R; Marsch S; Rüegg S
CNS Drugs; 2013 Apr; 27(4):321-9. PubMed ID: 23533010
[TBL] [Abstract][Full Text] [Related]
14. Intravenous lacosamide or phenytoin for treatment of refractory status epilepticus.
Kellinghaus C; Berning S; Stögbauer F
Acta Neurol Scand; 2014 May; 129(5):294-9. PubMed ID: 23937330
[TBL] [Abstract][Full Text] [Related]
15. Lacosamide in children with refractory status epilepticus. A multicenter Italian experience.
Grosso S; Zamponi N; Bartocci A; Cesaroni E; Cappanera S; Di Bartolo R; Balestri P
Eur J Paediatr Neurol; 2014 Sep; 18(5):604-8. PubMed ID: 24836405
[TBL] [Abstract][Full Text] [Related]
16. Intravenous lacosamide--an effective add-on treatment of refractory status epilepticus.
Albers JM; Möddel G; Dittrich R; Steidl C; Suntrup S; Ringelstein EB; Dziewas R
Seizure; 2011 Jun; 20(5):428-30. PubMed ID: 21354831
[TBL] [Abstract][Full Text] [Related]
17. Lacosamide in status epilepticus: Systematic review of current evidence.
Strzelczyk A; Zöllner JP; Willems LM; Jost J; Paule E; Schubert-Bast S; Rosenow F; Bauer S
Epilepsia; 2017 Jun; 58(6):933-950. PubMed ID: 28295226
[TBL] [Abstract][Full Text] [Related]
18. Intravenous lacosamide for treatment of status epilepticus.
Kellinghaus C; Berning S; Immisch I; Larch J; Rosenow F; Rossetti AO; Tilz C; Trinka E
Acta Neurol Scand; 2011 Feb; 123(2):137-41. PubMed ID: 20868429
[TBL] [Abstract][Full Text] [Related]
19. Intravenous lacosamide in refractory seizure clusters and status epilepticus: comparison of 200 and 400 mg loading doses.
Legros B; Depondt C; Levy-Nogueira M; Ligot N; Mavroudakis N; Naeije G; Gaspard N
Neurocrit Care; 2014 Jun; 20(3):484-8. PubMed ID: 23896816
[TBL] [Abstract][Full Text] [Related]
20. Adjunctive lacosamide in clinical practice: sodium blockade with a difference?
Stephen LJ; Kelly K; Parker P; Brodie MJ
Epilepsy Behav; 2011 Nov; 22(3):499-504. PubMed ID: 21890421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
